Calreticulin was previously identified from proteomic studies as having increased levels in iPSC-derived motor neurons from type I SMA patients [64] and in SMA mouse muscle [21], and this was verified biochemically in muscles from SMA mice and SMA patients [21]. Here, CALR is linked to proximal spinal muscular atrophy.